TABLE 2.
Virus | Amino acid at positionc:
|
Cytopathic effectd in:
|
|||
---|---|---|---|---|---|
451 | 481 | 416 | B95-8 | Vero | |
Vaccine strainsa | V | Y | D | + | + |
Edmonston (Vero cell adapted) | V | Y | D | + | + |
Group 1 wild typeb (China 93-5) | V | N | D | + | − |
Group 2 wild typeb (Montefiore 89, Chicago-1) | V | N | N | + | − |
Group 3 wild typeb (Colorado 1994) | V | N | N | + | − |
Group 4 wild typeb (New Jersey 94) | V | N | D | + | − |
Group 5 wild typeb (Tennessee) | K | N | D | + | − |
Group 8 wild typeb (China 93-1) | V | N | D | + | − |
Moraten, Rubeovax, Zagreb, Schwarz, and AIK-C vaccine strains were tested.
All wild-type viruses were initially isolated with B95-8 cells.
Predicted amino acids in the H protein including the potential glycosylation site at residue 416.
B95-8 and Vero cells were infected and examined for the presence (+) or absence (−) of cytopathic effect.